FCTGX vs. NCLEX

Last updated Jun 4, 2026

FCTGX (Fidelity Advisor Small Cap Growth Fund Class M) and NCLEX (Nicholas Limited Edition Fund) are both Small Cap Growth Equities funds. Over the past 10 years, FCTGX returned 14.11%/yr vs 7.27%/yr for NCLEX. Their correlation of 0.92 suggests significant overlap in exposure. FCTGX charges 1.54%/yr vs 0.85%/yr for NCLEX.

Performance

FCTGX vs. NCLEX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Advisor Small Cap Growth Fund Class M (FCTGX) and Nicholas Limited Edition Fund (NCLEX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FCTGX achieves a 18.31% return, which is significantly higher than NCLEX's -6.20% return. Over the past 10 years, FCTGX has outperformed NCLEX with an annualized return of 14.11%, while NCLEX has yielded a comparatively lower 7.27% annualized return.

FCTGX

• 1D: 0.80%
• 1M: 4.14%
• YTD: 18.31%
• 6M: 16.29%
• 1Y: 37.22%
• 3Y*: 20.17%
• 5Y*: 7.78%
• 10Y*: 14.11%

NCLEX

• 1D: -0.63%
• 1M: 1.63%
• YTD: -6.20%
• 6M: -7.32%
• 1Y: -11.96%
• 3Y*: 0.87%
• 5Y*: -0.95%
• 10Y*: 7.27%

*Multi-year figures are annualized to reflect compound growth (CAGR)

FCTGX vs. NCLEX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FCTGX Fidelity Advisor Small Cap Growth Fund Class M	18.31%	10.58%	19.92%	18.39%	-25.72%	9.89%	35.65%	35.62%	-5.10%	28.28%
NCLEX Nicholas Limited Edition Fund	-6.20%	-10.41%	11.91%	17.17%	-23.71%	19.07%	22.67%	27.36%	-0.94%	19.93%

Correlation

The correlation between FCTGX and NCLEX is 0.70, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.70
Correlation (3Y) Calculated over the trailing 3-year period	0.84
Correlation (5Y) Calculated over the trailing 5-year period	0.89
Correlation (10Y) Calculated over the trailing 10-year period	0.90
Correlation (All Time) Calculated using the full available price history since Nov 5, 2004	0.92

Over the past year, the correlation between FCTGX and NCLEX has dropped to 0.70 - well below their long-term average of 0.92, suggesting their price drivers have been diverging.

Return for Risk

FCTGX vs. NCLEX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FCTGX

FCTGX Risk / Return Rank: 46
FCTGX Sharpe Ratio Rank: 40
FCTGX Sortino Ratio Rank: 37
FCTGX Omega Ratio Rank: 35
FCTGX Calmar Ratio Rank: 59
FCTGX Martin Ratio Rank: 60

NCLEX

NCLEX Risk / Return Rank: 1
NCLEX Sharpe Ratio Rank: 1
NCLEX Sortino Ratio Rank: 1
NCLEX Omega Ratio Rank: 1
NCLEX Calmar Ratio Rank: 1
NCLEX Martin Ratio Rank: 1

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FCTGX vs. NCLEX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Small Cap Growth Fund Class M (FCTGX) and Nicholas Limited Edition Fund (NCLEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FCTGX	NCLEX	Difference
Sharpe ratio: Return per unit of total volatility	1.86	-0.64	+2.50
Sortino ratio: Return per unit of downside risk	2.54	-0.81	+3.35
Omega ratio: Gain probability vs. loss probability	1.31	0.91	+0.40
Calmar ratio: Return relative to maximum drawdown	2.97	-0.51	+3.48
Martin ratio: Return relative to average drawdown	11.97	-1.06	+13.02
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FCTGX vs. NCLEX - Sharpe Ratio Comparison

The current FCTGX Sharpe Ratio is 1.86, which is higher than the NCLEX Sharpe Ratio of -0.64. The chart below compares the historical Sharpe Ratios of FCTGX and NCLEX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	FCTGX	NCLEX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.86	-0.64	+2.50
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.33	-0.05	+0.38
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.62	0.38	+0.24
Sharpe Ratio (All Time) Calculated using the full available price history	0.49	0.51	-0.03

Drawdowns

FCTGX vs. NCLEX - Drawdown Comparison

The maximum FCTGX drawdown since its inception was -61.25%, which is greater than NCLEX's maximum drawdown of -48.68%. Use the drawdown chart below to compare losses from any high point for FCTGX and NCLEX.

Drawdown Indicators

	FCTGX	NCLEX	Difference
Max Drawdown Largest peak-to-trough decline	-61.25%	-48.68%	-12.57%
Max Drawdown (1Y) Largest decline over 1 year	-13.22%	-21.36%	+8.14%
Max Drawdown (3Y) Largest decline over 3 years	-28.84%	-28.50%	-0.34%
Max Drawdown (5Y) Largest decline over 5 years	-39.21%	-28.50%	-10.71%
Max Drawdown (10Y) Largest decline over 10 years	-39.21%	-35.79%	-3.42%
Current Drawdown Current decline from peak	-0.39%	-21.53%	+21.14%
Average Drawdown Average peak-to-trough decline	-11.60%	-8.28%	-3.32%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.28%	10.19%	-6.91%

Volatility

FCTGX vs. NCLEX - Volatility Comparison

Fidelity Advisor Small Cap Growth Fund Class M (FCTGX) has a higher volatility of 6.47% compared to Nicholas Limited Edition Fund (NCLEX) at 5.11%. This indicates that FCTGX's price experiences larger fluctuations and is considered to be riskier than NCLEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FCTGX	NCLEX	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.47%	5.11%	+1.36%
Volatility (6M) Calculated over the trailing 6-month period	16.32%	12.12%	+4.20%
Volatility (1Y) Calculated over the trailing 1-year period	21.18%	16.90%	+4.28%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	23.47%	19.52%	+3.95%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	22.85%	19.21%	+3.64%

FCTGX vs. NCLEX - Expense Ratio Comparison

FCTGX has a 1.54% expense ratio, which is higher than NCLEX's 0.85% expense ratio.

Dividends

FCTGX vs. NCLEX - Dividend Comparison

FCTGX's dividend yield for the trailing twelve months is around 6.29%, less than NCLEX's 8.03% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FCTGX Fidelity Advisor Small Cap Growth Fund Class M	6.29%	7.44%	1.07%	0.00%	0.00%	21.26%	8.90%	5.81%	15.13%	7.17%	0.81%	4.23%
NCLEX Nicholas Limited Edition Fund	8.03%	7.53%	2.51%	2.43%	6.22%	16.44%	5.10%	5.66%	10.72%	7.97%	10.68%	8.05%

Frequently Asked Questions

Can I hold both FCTGX and NCLEX in my portfolio?

FCTGX and NCLEX have a correlation of 0.70, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FCTGX or NCLEX?

FCTGX has higher volatility (6.47%) compared to NCLEX (5.11%). In terms of maximum drawdown, FCTGX dropped -61.25% vs NCLEX's -48.68%.

Which has better risk-adjusted returns?

FCTGX currently has the higher Sharpe Ratio (1.86 vs -0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.